Company / Inventory
NovaBay Pharmaceuticals, Inc. Inventory History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$765.0K
FY2024
5-year range
$501.0K / $3.4M
FY2020-FY2024
Trend
+52.7%
vs FY2023
Sector context
#105 of 108
Health Care
What the data says
Among 108 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 3% for inventory. Inventory has fluctuated over the past 10 years, ranging from $280,000 in FY2018 to $3M in FY2022.
Based on SEC 10-K filings.
$765,000 in FY2024 with a 5-year CAGR of +9.2%.
Declined from $3M to $765,000 over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -38.1%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 108This company $765.0K Sector average $862.4M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.2%, indicating consistent growth.
- In FY2024, inventory increased 52.7% year-over-year.
- Ranks #105 out of 108 companies in the Health Care sector.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $765.0K | +52.7% |
| FY2023 | $501.0K | -85.4% |
| FY2022 | $3.4M | +6.7% |
| FY2021 | $3.2M | +429.6% |
| FY2020 | $608.0K | +23.6% |
| FY2019 | $492.0K | +75.7% |
| FY2018 | $280.0K | -44.4% |
| FY2017 | $504.0K | -42.3% |
| FY2016 | $873.0K | -35.1% |
| FY2015 | $1.3M | +158.2% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026